ChemicalBook >> CAS DataBase List >>GSK2256294A
GSK2256294A
- CAS No.
- 1142090-23-0
- Chemical Name:
- GSK2256294A
- Synonyms
- GSK2256294A;GSK 2256294A - GSK 2256294;GSK 2256294;GSK-2256294;GSK2256294;GSK-2256294A;GSK2256294A;Cyclohexanecarboxamide, N-[[4-cyano-2-(trifluoromethyl)phenyl]methyl]-3-[[4-methyl-6-(methylamino)-1,3,5-triazin-2-yl]amino]-, (1R,3S)-;GSK-2256294,GSK-2256294A,GSK2256294A,Inhibitor,Epoxide Hydrolase,GSK2256294,inhibit,cigarette smoke-exposure model,oral,COPD,cardiovascular,inflammation
- CBNumber:
- CB83067008
- Molecular Formula:
- C21H24F3N7O
- Molecular Weight:
- 447.46
- MDL Number:
- MFCD27987923
- MOL File:
- 1142090-23-0.mol
- MSDS File:
- SDS
Last updated:2023-09-05 10:22:04
| Density | 1.34±0.1 g/cm3(Predicted) |
|---|---|
| storage temp. | Store at -20°C |
| solubility | DMSO : ≥ 47 mg/mL (105.04 mM) |
| pka | 14.75±0.40(Predicted) |
| InChIKey | LQHDJQIMETZMPH-ZBFHGGJFSA-N |
| SMILES | [C@@H]1(C(NCC2=CC=C(C#N)C=C2C(F)(F)F)=O)CCC[C@H](NC2=NC(C)=NC(NC)=N2)C1 |
| FDA UNII | L33EX3XR0T |
GSK2256294A price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| TRC | G797420 | GSK2256294 | 1142090-23-0 | 50mg | $1470 | 2021-12-16 | Buy |
| ChemScene | CS-5395 | GSK2256294A 99.51% | 1142090-23-0 | 5mg | $264 | 2021-12-16 | Buy |
| ChemScene | CS-5395 | GSK2256294A 99.51% | 1142090-23-0 | 10mg | $420 | 2021-12-16 | Buy |
| Axon Medchem | Axon2220 | GSK2256294A-GSK2256294 99% | 1142090-23-0 | 5mg | $203.5 | 2021-12-16 | Buy |
| ChemScene | CS-5395 | GSK2256294A 99.51% | 1142090-23-0 | 50mg | $1020 | 2021-12-16 | Buy |
GSK2256294A Preparation Products And Raw materials
Raw materials
Preparation Products
GSK2256294A Suppliers
Global( 36)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19553 | 58 |
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32480 | 60 |
| TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 19892 | 58 |
| InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6393 | 58 |
| Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 | sales@molcore.com | China | 49739 | 58 |
| Aladdin Scientific | +1-833-552-7181 | sales@aladdinsci.com | United States | 52927 | 58 |
| Haoyuan Chemexpress Co., Ltd. | 021-58950125 | info@chemexpress.com | China | 7553 | 61 |
| MedChemexpress LLC | 021-58955995 | sales@medchemexpress.cn | United States | 4863 | 58 |
| Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 | info@efebio.com | China | 9709 | 58 |
| Qingdao IniKem BioPharmaTech Co.,Ltd | 18561687109 | sales@inikem.com | China | 289 | 55 |
GSK2256294A
GSK 2256294;GSK-2256294;GSK2256294;GSK-2256294A;GSK2256294A
GSK 2256294A - GSK 2256294
Cyclohexanecarboxamide, N-[[4-cyano-2-(trifluoromethyl)phenyl]methyl]-3-[[4-methyl-6-(methylamino)-1,3,5-triazin-2-yl]amino]-, (1R,3S)-
GSK-2256294,GSK-2256294A,GSK2256294A,Inhibitor,Epoxide Hydrolase,GSK2256294,inhibit,cigarette smoke-exposure model,oral,COPD,cardiovascular,inflammation
1142090-23-0
C21H24F3N7O